Product Information
VERAPAMIL ER 240 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1654 per EA under NDC 75834015905. Its NADAC has been published 371 times since Jul 17, 2019.
FDA first approved this application on May 5, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834015905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206173FDA Approved
5/5/2017
TE Code
AB
On Market Since
5/15/2019
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 240 MG TABLET has been published 371 times since Jul 17, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1654 per EA |
|---|---|
| All-time high | $0.2329 (Aug 12, 2020) |
| All-time low | $0.1458 (Nov 20, 2024) |
| 52-week high | $0.1790 |
| 52-week low | $0.1586 |
| Median price | $0.1706 |
| Average price | $0.1824 |
| Largest weekly change | +22.4% (Sep 18, 2019) |
| Weeks tracked | 371 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 240 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 240 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1654 per EA (NDC 75834015905), effective Aug 19, 2026.
How has the price of VERAPAMIL ER 240 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 240 MG TABLET has held within roughly two percent of its current level. It has been tracked across 371 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 240 MG TABLET?
Since Jul 17, 2019, the NADAC for VERAPAMIL ER 240 MG TABLET has ranged from a low of $0.1458 (Nov 20, 2024) to a high of $0.2329 (Aug 12, 2020), with a median of $0.1706 per EA.
Are there cheaper alternatives to VERAPAMIL ER 240 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL ER 240 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL ER 240 MG TABLET?
VERAPAMIL ER 240 MG TABLET (NDC 75834015905) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.